Ras history: The saga continues

Cited by (712)

Items 401–500 of 712

1. Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
   Luka Brčić, Marko Jakopović, Marija Mišić, Fran Seiwerth, Izidor Kern, Silvana Smojver‐Ježek, Franz Quehenberger, Miroslav Samaržija, Sven Seiwerth · 2016 · Diagnostic Pathology
2. In vivo and in vitro expression of the RASAL1 gene in human gastric adenocarcinoma and its clinicopathological significance
   Hong Chen, Xiaowei Yang, Hui Zhang, Qing Yang, Zhi Wang, Yang Liu, Feng-lin Lu, Baoyi Zhou, CHENG-HUI QIU-XI, SHENG-LIN LU · 2011 · Oncology Letters
3. Breaking up is hard to do: RalA, mitochondrial fission and cancer
   Kashatus, David F., Counter, Christopher M. · 2011 · Small GTPases
4. In Silico Analysis of nsSNPs of Human KRAS Gene and Protein Modeling Using Bioinformatic Tools
   Duoduo Xu, Qiqi Shao, Chen Zhou, Arif Mahmood, Jizhou Zhang · 2023 · ACS Omega
5. Molecular docking analysis of KRAS inhibitors for cancer management
   Qamre Alam · 2023 · Bioinformation
6. The structure of KRAS G12C bound to divarasib highlights features of potent switch-II pocket engagement
   Micah C. Fernando, Gregory B. Craven, Kevan M. Shokat · 2024 · Small GTPases
7. Inhibitors of the ERK mitogen-activated protein kinase cascade for targeting RAS mutant cancers.
   Leanna R. Gentry, A. Samatar, C. Der · 2013 · The Enzymes
8. Oncogenic N-Ras Stimulates SRF-Mediated Transactivation via H3 Acetylation at Lysine 9
   Sun-Ju Yi, Seong Yun Hwang, Myung-Ju Oh, Yang‐Hoon Kim, Hojin Ryu, Sung‐Keun Rhee, Byung Hak Jhun, Kyunghwan Kim · 2018 · BioMed Research International
9. Identification and biochemical characterisation of Acanthamoeba castellanii cysteine protease 3
   Zhixin Wang, Duo Wu, Hiroshi Tachibana, Meng Feng, Xunjia Cheng · 2020 · Parasites & Vectors
10. Clinical characteristics of pancreatic and biliary tract cancers associated with Lynch syndrome
    Shigemasa Takamizawa, Chigusa Morizane, Noriko Tanabe, Yuta Maruki, Shunsuke Kondo, Susumu Hijioka, Hideki Ueno, Kokichi Sugano, Nobuyoshi Hiraoka, Takuji Okusaka · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
11. Megaviruses contain various genes encoding for eukaryotic vesicle trafficking factors
    Dany Khalifeh, Émilie Neveu, Dirk Fasshauer · 2022 · Traffic
12. MicroRNA‐Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer
    Sriganesh B. Sharma, John Michael Ruppert · 2015 · Drug Development Research
13. DA-Raf, a dominant-negative antagonist of the Ras–ERK pathway, is a putative tumor suppressor
    Emiri Kanno, Osamu Kawasaki, Kazuya Takahashi, Kazunori Takano, Takeshi Endo · 2017 · Experimental Cell Research
14. Synthesis of Ras proteins and their application in biofunctional studies
    Jun Hu, Pengcheng Zhu, Yanmei Li, Yong‐Xiang Chen · 2018 · Chinese Chemical Letters
15. Three distinct regions of cRaf kinase domain interact with membrane
    Priyanka Prakash, John F. Hancock, Alemayehu Abebe Gorfe · 2019 · Scientific Reports
16. EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells
    Yuehong Chen, Hao Lv, Ning Shen, Xiaomin Wang, Shuai Tang, Bing Xiong, Jian Ding, Meiyu Geng, Min Huang · 2019 · Acta Pharmacologica Sinica
17. Novel insights into the pathogenesis and treatment of NRAS mutant melanoma
    Jeffrey W. Zhao, Carlos Galvez, Kathryn Eby Beckermann, Douglas Buckner Johnson, Jeffrey Alan Sosman · 2021 · Expert Review of Precision Medicine and Drug Development
18. A novel antiproliferative PKCα-Ras-ERK signaling axis in intestinal epithelial cells
    Navneet Kaur, Michelle A. Lum, Robert E. Lewis, Adrian R. Black, Jennifer D. Black · 2022 · Journal of Biological Chemistry
19. The IQGAP-related protein DGAP1 mediates signaling to the actin cytoskeleton as an effector and a sequestrator of Rac1 GTPases
    Vedrana Filić, Maja Marinović, Jan Faix, I.T. Weber · 2014 · Cellular and Molecular Life Sciences
20. Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutations
    Swarnendu Tripathi, Nikita R. Dsouza, Raul A. Urrutia, Michael T. Zimmermann · 2020 · Bioinformatics
21. A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications
    Yildirim, Hasan Cagri, Gunenc, Damla, Almuradova, Elvina, Sutcuoglu, Osman, Yalcin, Suayib · 2025 · Medicina
22. The motor-clutch model in mechanobiology and mechanomedicine
    Xu Zhao, Feng Xu, Bo Cheng · 2024 · Mechanobiology in Medicine
23. Discovery of RGT-018: A Potent, Selective, and Orally Bioavailable SOS1 Inhibitor for KRAS-Driven Cancers
    Fei Xiao, Kailiang Wang, Xinjuan Wang, Huijuan Li, Zhilong Hu, Xiaoming Ren, Wei Huang, Teng Feng, Lili Yao, Jing Lin et al. · 2024 · Molecular Cancer Therapeutics
24. Open pipelines for integrated tumor genome profiles reveal differences between pancreatic cancer tumors and cell lines
    Jeremy Goecks, Bassel F. El‐Rayes, Shishir Kumar Maithel, H. Jean Khoury, James Taylor, Michael R. Rossi · 2015 · Cancer Medicine
25. Neuroepithelial cell competition triggers loss of cellular juvenescence
    Faidruz Azura Jam, Takao Morimune, Atsushi Tsukamura, Ayami Tano, Yuya Tanaka, Yasuhiro Mori, Takefumi Yamamoto, Masaki Nishimura, Ikuo Tooyama, Masaki Mori · 2020 · Scientific Reports
26. Sotorasib – an inhibitor of KRAS p.G12c mutation in advanced non-small cell carcinoma
    Amit Kumar Agrawal, Ramya Pragya, Amit Choudhary, Anuj Kumar Gupta, Kuraparthy Sambasivaiah, Bal Krishna Mishra, Satvik Khaddar, Akhil Kapoor · 2021 · Cancer Research Statistics and Treatment
27. Ras Multimers on the Membrane: Many Ways for a Heart-to-Heart Conversation
    E. Sıla Özdemir, Anna Magdalena Koester, Xiaolin Nan · 2022 · Genes
28. Unraveling and targeting RAS-driven metabolic signaling for therapeutic gain
    Jonathan M. DeLiberty, Ryan N. Robb, Claire E. Gates, Kirsten L. Bryant · 2022 · Advances in cancer research
29. TGFβ-induced changes in membrane curvature influence Ras oncoprotein membrane localization
    Alexandros F. Damalas, Ivana Vonkova, Marijonas Tutkus, Dimitrios G. Stamou · 2022 · Scientific Reports
30. Molecular Dynamics of Enzyme-Substrate Complexes in Guanosine Trifosphate-Binding Proteins
    Maria G. Khrenova, Igor V. Polyakov, Alexander V. Nemukhin · 2022 · Russian Journal of Physical Chemistry B
31. Identification of Potential Inhibitors Targeting GTPase-Kirsten RAt Sarcoma Virus (K-Ras) Driven Cancers via E-Pharmacophore-Based Virtual Screening and Drug Repurposing Approach
    S. Udhaya Kumar, Rinku Polachirakkal Varghese, V. Anu Preethi, C. George Priya Doss, Hatem Zayed · 2023 · Frontiers in Bioscience-Landmark
32. Dominant-negative antagonists of the Ras–ERK pathway: DA-Raf and its related proteins generated by alternative splicing of Raf
    Takeshi Endo · 2019 · Experimental Cell Research
33. Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer
    Liyuan Gao, Weizhang Shen · 2022 · Frontiers in Genetics
34. Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
    Lucien Torlot, Anna Jarząb, Johanna Albert, Ágnes Pók-Udvari, Arndt Stahler, Julian Walter Holch, Marco Gerlinger, Volker Heinemann, Frederick Klauschen, Thomas Kirchner et al. · 2022 · Journal of Cancer Research and Clinical Oncology
35. Molecular docking and simulation of Curcumin with Geranylgeranyl Transferase1 (GGTase1) and Farnesyl Transferase (FTase)
    Parasuraman Aiya Subramani, Venkata Ramireddy Narala, Rajamani Dinakaran Michael, Dakshayani Lomada, Madhava C. Reddy · 2015 · Bioinformation
36. What drives the clustering of membrane-bound Ras?
    Zhenlong Li, Alemayehu Abebe Gorfe · 2012 · Small GTPases
37. Targeting endogenous K-RAS for degradation through the affinity-directed protein missile system
    Sascha Röth, Thomas Macartney, Agnieszka Konopacka, Markus A. Queisser, Gopal P. Sapkota · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
38. Advances in the Treatment of Rare Mutations in Non-Small Cell Lung Cancer
    Yanning Sun, Li Ma, Xiaofei Zhang, Zhaoxia Wang · 2024 · OncoTargets and Therapy
39. Melanoma: Pathogenesis and Targeted Therapy
    Yang Fu, Jie Liu, Zeming Mo, Bin Wang, Yaotiao Deng, Y. Jiang · 2026 · MedComm
40. Direkte Modulation von Aktivität und Funktion kleiner GTPasen
    Philipp M. Cromm, Jochen Spiegel, Tom N. Grossmann, Herbert Waldmann · 2015 · Angewandte Chemie
41. Neurofibromatosis as a gateway to better treatment for a variety of malignancies
    Annette C. Bakker, Salvatore La Rosa, Larry S. Sherman, Pamela B. Knight, Hye-Rim Lee, Patrice Pancza, Marco Nievo · 2016 · Progress in Neurobiology
42. HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature
    Laurent Mathiot, Guillaume Herbreteau, Siméon Robin, Charlotte Fenat, Jaafar Bennouna, Christophe Blanquart, Marc Guillaume Denis, Elvire Pons Tostivint · 2022 · Current Oncology
43. Conformational ensemble-dependent lipid recognition and segregation by prenylated intrinsically disordered regions in small GTPases
    Mussie K. Araya, Alemayehu Abebe Gorfe · 2023 · Communications Biology
44. Miro GTPases at the Crossroads of Cytoskeletal Dynamics and Mitochondrial Trafficking
    Pontus Aspenström · 2024 · Cells
45. Weighted gene co-expression network analysis and whole genome sequencing identify potential lung cancer biomarkers
    Mireguli Abudereheman, Zhengjun Lian, Baidurula Ainitu · 2024 · Frontiers in Oncology
46. Krüppel‐like factor 6 interferes with cellular transformation induced by the H‐ ras oncogene
    Lucas Daniel Trucco, Verónica Andreoli, Nicolás Gonzalo Núñez, Mariana Maccioni, José Luís Bocco · 2014 · The FASEB Journal
47. Why does mutation of G ln61 in Ras by the nitro analog NG ln maintain activity of R as‐ GAP in hydrolysis of guanosine triphosphate?
    Maria G. Khrenova, Bella L. Grigorenko, Vladimir A. Mironov, Alexander V. Nemukhin · 2015 · Proteins Structure Function and Bioinformatics
48. NMR Study to Identify a Ligand-Binding Pocket in Ras
    Till Maurer, Weiru Wang · 2013 · The Enzymes
49. The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers
    Gajendra Shrestha, Shelley M. MacNeil, Jasmine A. McQuerry, David F. Jenkins, Sunil Sharma, Andrea H. Bild · 2016 · Seminars in Cell and Developmental Biology
50. Médecine de précision et médecine des systèmes: La médecine personnalisée se trompet-elle de cible ?
    Marie Darrason · 2017 · Lato Sensu Revue de la Société de philosophie des sciences
51. An Application of pET SUMO Protein Expression System in Escherichia coli: Cloning, Expression, Purification, and Characterisation of Native Kras4BG12V Oncoprotein
    Michelle Siying Tan, Yuan Han Teh, Kok Lian Ho, Johnson Stanslas · 2019 · The Protein Journal
52. HPLC Method to Resolve, Identify and Quantify Guanine Nucleotides Bound to the GTPase Ras
    Jonathan P. Hannan, G. Hayden Swisher, Justin G. Martyr, Nicholas J. Cordaro, Annette H. Erbse, Joseph J. Falke · 2021 · Analytical Biochemistry
53. Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)
    Lihua Shu, Dongsheng Wang, Sreenivas Nannapaneni, Youzhi Sun, Christopher C Griffith, Xu Wang, Zhengjia Chen, Mihir R. Patel, Mark W. El‐Deiry, Dong Moon Shin et al. · 2021 · Oral Oncology
54. Conformational SERS Classification of K‐Ras Point Mutations for Cancer Diagnostics
    Judit Morlà‐Folch, Patricia Gisbert‐Quilis, Matteo Masetti, Eduardo García‐Rico, Ramón A. Álvarez‐Puebla, Luca Guerrini · 2017 · Angewandte Chemie
55. The discovery of some promising putative binders of KRAS G12D receptor using computer-aided drug discovery approach
    Abdul-Quddus Kehinde Oyedele, Nurudeen Owolabi, Tope Tunji Odunitan, Abosede Christiana Ajibare, Rukayat Olajumoke Jimoh, Waliu O. Abdulazeez, Maryam Bello-Hassan Titilayo, Abiola Sarah Soares, Adedayo Toluwani Adekola, Teslim Oluwaseyi Abdulkareem et al. · 2023 · Informatics in Medicine Unlocked
56. Synthetic Lethal Genetic Screens in Ras Mutant Cancers
    Bing Yu, Ji Luo · 2013 · The Enzymes
57. Reaction Mechanism of Guanosine Triphosphate Hydrolysis by the Vision-Related Protein Complex Arl3–RP2
    Maria G. Khrenova, Ekaterina D. Kots, Alexander V. Nemukhin · 2016 · The Journal of Physical Chemistry B
58. Different molecular recognition by three domains of the full-length GRB2 to SOS1 proline-rich motifs and EGFR phosphorylated sites
    Keita Tateno, Takami Ando, Maako Tabata, Haruka Sugasawa, Toshifumi Hayashi, Sangya Yu, Pooppadi Maxin Sayeesh, Kohsuke Inomata, Tsutomu Mikawa, Yutaka Ito et al. · 2024 · Chemical Science
59. Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation
    Taehyang Lee, Kyung Kim, Jeeyun Lee, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park, Seung Tae Kim · 2018 · Journal of Cancer
60. KRAS-targeted therapy in the treatment of non-small cell lung cancer
    Jina Yun, Reid Nakagawa, Kenneth W. Tham · 2022 · Journal of Oncology Pharmacy Practice
61. CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
    Mithila Tennakoon, Waruna Thotamune, John L. Payton, Ajith Karunarathne · 2023 · Journal of Biological Chemistry
62. RHOAL57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling
    Antje Schaefer, Richard G. Hodge, Haisheng Zhang, G. Aaron Hobbs, Julien Dilly, Minh V. Huynh, Craig M. Goodwin, Feifei Zhang, J. Nathaniel Diehl, Mariaelena Pierobon et al. · 2023 · Science Signaling
63. Ras Chaperones
    Yoel Kloog, Galit Elad‐Sfadia, Roni Haklai, Adam Mor · 2013 · The Enzymes
64. Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine
    Ana Laura Guzmán-Ortiz, Gerardo Aparicio‐Ozores, Ricardo Valle‐Rios, Oscar Medina Contreras, Genaro Patiño‐López, Héctor Quezada · 2017 · Boletín Médico del Hospital Infantil de México
65. Targeting the “undruggable” RAS - new strategies - new hope?
    Britta Mörchen, Oleksandr Shkura, Raphael Stoll, Iris Helfrich · 2019 · Cancer Drug Resistance
66. KRAS as Potential Target in Colorectal Cancer Therapy
    Shu-Kee Eng, Teng Hern Tan Loh, Bey Hing Goh, Wai-Leng Lee · 2019 · Springer eBooks
67. Presence or Absence of Ras Dimerization Shows Distinct Kinetic Signature in Ras-Raf Interaction
    Sumantra Sarkar, Angel E. Garcı́a · 2020 · Biophysical Journal
68. K-RAS4A: Lead or Supporting Role in Cancer Biology?
    Veronica Aran · 2021 · Frontiers in Molecular Biosciences
69. Biochemical characterization of the interaction between KRAS and Argonaute 2
    Jessica J. Waninger, Tyler S. Beyett, Varun V. Gadkari, Ronald F. Siebenaler, Carson Kenum, Sunita Shankar, Brandon T. Ruotolo, Arul M. Chinnaiyan, John J. G. Tesmer · 2021 · Biochemistry and Biophysics Reports
70. Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation
    Khuchtumur Bum‐Erdene, Mona K. Ghozayel, David Daqiang Xu, Samy O. Meroueh · 2022 · ChemMedChem
71. Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C
    Nicholas Endres, Steven Do, Rana M Mroue, Jack A. Terrett, Matt Saabye, Angela Oh, Thomas Hunsaker, Emily Chan, John C. Tran (1471192), Lan K. Nguyen et al. · 2026 · Journal of Medicinal Chemistry
72. Integrated pipeline for ultrasensitive protein detection in cancer nanomedicine
    Chi‐An Cheng, Li‐Chiao Chiang, Yu‐Syuan Chu · 2023 · RSC Advances
73. Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy
    Seung‐been Lee, Ji‐Won Kim, Hong-Geun Kim, Sung‐Hyun Hwang, Kui‐Jin Kim, Ju Hyun Lee, Jeongmin Seo, Min-Su Kang, Eun Hee Jung, Koung Jin Suh et al. · 2024 · Cancer Research and Treatment
74. Endogenous oncogenic KRAS expression increases cell proliferation and motility in near-diploid hTERT RPE-1 cells
    Naushin L. Hindul, Lauren R. Abbott, Sumaya M.D. Adan, Kees R. Straatman, Andrew M. Fry, Kouji Hirota, Kayoko Tanaka · 2024 · Journal of Biological Chemistry
75. Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
    Vida Tajiknia, Maximilian P. Pinho-Schwermann, Praveen R. Srinivasan, Liz J. Hernández Borrero, Leiqing Zhang, Kelsey E. Huntington, Wafik S. El‐Deiry · 2024 · American Journal of Cancer Research
76. A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize Signaling
    Monique J. Kauke, Alison W. Tisdale, Ryan L. Kelly, Christian Joerg Braun, Michael T. Hemann, Karl Dane Wittrup · 2018 · Molecular Cancer Therapeutics
77. Structural and functional characterization of fast-cycling RhoF GTPase
    Ryota Sugawara, Hiroshi Ueda, Ryo P. Honda · 2019 · Biochemical and Biophysical Research Communications
78. Identification of single-nucleotide variants associated with susceptibility to Salmonella in pigs using a genome-wide association approach
    Corinne H. Schut, Abdolvahab Farzan, Russell S. Fraser, Margaret H. Ainslie-Garcia, Robert M Friendship, Brandon N. Lillie · 2020 · BMC Veterinary Research
79. The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
    Heather Poad, Sam Khan, Lorna Wheaton, Anne Thomas, Michael J. Sweeting, Sylwia Bujkiewicz · 2022 · Cancers
80. Enhanced proliferation in a prawn embryonic primary cell culture ectopically expressing mutated Ras
    Gurucharan Sudarshan, Simy Weil, Noa Rotem‐Dai, Rivka Manor, Yariv Greenshpan, Oron Goldstein, Omri Sharabi, Eliahu David Aflalo, Rivka Ofir, Benyamin Rosental et al. · 2023 · Frontiers in Marine Science
81. Computational Modeling of the Neurofibromin-Stimulated Guanosine Triphosphate Hydrolysis by the KRas Protein
    Igor V. Polyakov, Alexander V. Nemukhin · 2023 · Biophysica
82. An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
    Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, Rehab Mustafa Badi, Hoda Atef Abdelsattar Ibrahim, Eslam B. Elkaeed, Wagdy Mohamed Eldehna · 2024 · Molecular Diversity
83. Prenylation and Phosphorylation of Ras Superfamily Small GTPases
    Heather B. Hodges, Lauren E. Parker, Adrienne D. Cox · 2011 · The Enzymes
84. Metabolic profiling of gemcitabine- and paclitaxel-treated immortalized human pancreatic cell lines with K-RASG12D
    Akiko Todaka, Rina Umehara, Keiko Sasaki, Masakuni Serizawa, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi, Hirofumi Yasui · 2017 · Biomedical Research
85. A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    Xiufeng Pang, Mingyao Liu · 2016 · 癌症：英文版
86. A Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and Targets
    Haitao Chen, Robert E. Bird, Da-Sheng Wang, Leilani M. Lotti Diaz, Kavita A. Iyer, Gary R. Gustafson, Junko Kato-Weinstein, Qiongqiong Angela Zhou · 2023 · ChemRxiv
87. Open quantum systems theory of ultraweak ultraviolet photon emissions: Revisiting Gurwitsch's onion experiment as a prototype for quantum biology
    Nathan S. Babcock · 2024 · Computational and Structural Biotechnology Journal
88. Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
    Vineet Prajapati, Ankit Kumar Singh, Adarsh M Kumar, Harshwardhan Singh, Prateek Pathak, Maria Grishina, Vikas Kumar, Habibullah Khalilullah, Amita Verma, Pradeep Kumar · 2025 · RSC Medicinal Chemistry
89. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
90. Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer
    Hasan Alsharoh, Paul Adrian Chiroi, Ekaterina Isachesku, Radu Andrei Tanasa, Ovidiu Laurean Pop, Radu Pîrlog, Ioana Berindan‐Neagoe · 2024 · Biomedicines
91. Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
    Larissa Haertle, Umair Munawar, Hipólito Nicolás Cuesta Hernández, Andrés Arroyo-Barea, Tobias Heckel, Isabel Cuenca, Lucía Sánchez Martín, Carlotta Höschle, Nicole Müller, Cornelia Vogt et al. · 2024 · HemaSphere
92. Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer
    Behshid Ghadrdoost Nakhchi, Ramoji Kosuru, Magdalena Chrzanowska‐Wodnicka · 2024 · International Journal of Molecular Sciences
93. In vivo Functional Genomics for Undiagnosed Patients: The Impact of Small GTPases Signaling Dysregulation at Pan-Embryo Developmental Scale
    Antonella Lauri, Giulia Fasano, Martina Venditti, Bruno Dallapiccola, Marco Tartaglia · 2021 · Frontiers in Cell and Developmental Biology
94. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage
    Yaqi Du, Zhengguang Wang, Weina Wan · 2021 · Journal of Cancer
95. Immunohistochemical expressions of EMT markers in pan-RAS–pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients
    Kiran Tripathi, Niharika Maurya, Apul Goel, Atin Singhai, Minal Garg · 2022 · Molecular and Cellular Biochemistry
96. Binding of active Ras and its mutants to the Ras binding domain of PI-3-kinase: A quantitative approach to KD measurements
    Ian R Fleming, Jonathan P. Hannan, G. Hayden Swisher, Corey D Tesdahl, Justin G. Martyr, Nicholas J. Cordaro, Annette H. Erbse, Joseph J. Falke · 2022 · Analytical Biochemistry
97. Structural insights into the complex of oncogenic KRas4B G12V and Rgl2, a RalA/B activator
    Mishal Tariq, Teppei Ikeya, Naoyuki Togashi, Louise Fairall, Shun Kamei, Sannojah Mayooramurugan, Lauren R. Abbott, Anab Hasan, Carlos J. Bueno-Alejo, Sakura Sukegawa et al. · 2023 · Life Science Alliance
98. Posttranslational Modifications of Small G Proteins
    Bingying Zhou, Adrienne D. Cox · 2014 · Springer eBooks
99. Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies
    Aníbal Bueno, Ian Morilla, Diego Díez, Aurelio A. Moya‐García, José Lozano, Juan A. G. Ranea · 2016 · Oncotarget
100. Prevalence of K-ras Codon 12 Mutations in Indian Patients with Head and Neck Cancer
     Ashna Gauthaman, Anbalagan Moorthy · 2020 · Indian Journal of Clinical Biochemistry